1. Home
  2. BRTX vs MHUA Comparison

BRTX vs MHUA Comparison

Compare BRTX & MHUA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BRTX
  • MHUA
  • Stock Information
  • Founded
  • BRTX 1997
  • MHUA 1990
  • Country
  • BRTX United States
  • MHUA China
  • Employees
  • BRTX N/A
  • MHUA N/A
  • Industry
  • BRTX Managed Health Care
  • MHUA Medical Specialities
  • Sector
  • BRTX Health Care
  • MHUA Health Care
  • Exchange
  • BRTX Nasdaq
  • MHUA Nasdaq
  • Market Cap
  • BRTX 12.8M
  • MHUA 12.7M
  • IPO Year
  • BRTX N/A
  • MHUA 2022
  • Fundamental
  • Price
  • BRTX $1.50
  • MHUA $0.23
  • Analyst Decision
  • BRTX
  • MHUA
  • Analyst Count
  • BRTX 0
  • MHUA 0
  • Target Price
  • BRTX N/A
  • MHUA N/A
  • AVG Volume (30 Days)
  • BRTX 304.1K
  • MHUA 560.7K
  • Earning Date
  • BRTX 11-13-2025
  • MHUA 12-19-2025
  • Dividend Yield
  • BRTX N/A
  • MHUA N/A
  • EPS Growth
  • BRTX N/A
  • MHUA N/A
  • EPS
  • BRTX N/A
  • MHUA 0.29
  • Revenue
  • BRTX $605,200.00
  • MHUA $89,547,563.00
  • Revenue This Year
  • BRTX $232.67
  • MHUA N/A
  • Revenue Next Year
  • BRTX $52.92
  • MHUA N/A
  • P/E Ratio
  • BRTX N/A
  • MHUA $0.81
  • Revenue Growth
  • BRTX 247.62
  • MHUA N/A
  • 52 Week Low
  • BRTX $1.19
  • MHUA $0.21
  • 52 Week High
  • BRTX $2.55
  • MHUA $0.76
  • Technical
  • Relative Strength Index (RSI)
  • BRTX 42.27
  • MHUA 32.65
  • Support Level
  • BRTX $1.49
  • MHUA $0.23
  • Resistance Level
  • BRTX $1.70
  • MHUA $0.28
  • Average True Range (ATR)
  • BRTX 0.09
  • MHUA 0.04
  • MACD
  • BRTX -0.01
  • MHUA -0.01
  • Stochastic Oscillator
  • BRTX 14.81
  • MHUA 12.96

About BRTX BioRestorative Therapies Inc. (NV)

BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and the Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.

About MHUA Meihua International Medical Technologies Co. Ltd.

Meihua International Medical Technologies Co Ltd is engaged in providing disposable medical devices. It serves hospitals, pharmacies, medical institutions, and medical equipment companies. Its product offerings include a Disposable Medical mask, Disposable ID Bracelet, Disposable Artificial Anal bag, Disposable Catheter, and Electonic pump among others.

Share on Social Networks: